Raiffeisen Bank International’s Gilead Sciences GILD Stock Holding History

Raiffeisen Bank International’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.1M	Buy	198,926 +18,169	+10%	+$2.39M	0.29%	81
2026 Q1	$24.6M	Sell	180,757 -18,190	-9%	-$2.55M	0.35%	73
2025 Q4	$24.5M	Buy	198,947 +4,716	+2%	+$573K	0.32%	84
2025 Q3	$21.9M	Sell	194,231 -39,858	-17%	-$4.53M	0.29%	86
2025 Q2	$24.8M	Sell	234,089 -2,278	-1%	-$242K	0.37%	80
2025 Q1	$26.4M	Buy	236,367 +1,691	+0.7%	+$174K	0.42%	72
2024 Q4	$21.6M	Buy	+234,676	New	+$21.1M	0.33%	80

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Raiffeisen Bank International's GILD Position: Q2 2026 in Review

Raiffeisen Bank International increased its Gilead Sciences (GILD) stake by 10% in Q2 2026, buying an estimated $2.39M and bringing the position to 198,926 shares worth $25.1M. The position accounts for 0.29% of the portfolio, ranked #81.

Raiffeisen Bank International first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $26.4M in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Raiffeisen Bank International held 198,926 shares of Gilead Sciences worth $25.1M as of Q2 2026.
Raiffeisen Bank International bought 18,169 Gilead Sciences shares in Q2 2026, an estimated $2.39M.
Gilead Sciences made up 0.29% of Raiffeisen Bank International's portfolio in Q2 2026, its #81 holding.
Raiffeisen Bank International first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
Raiffeisen Bank International's Gilead Sciences position peaked at $26.4M in Q1 2025.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.